← Back to All Filings

Synopsys (SNPS) CRO Awarded Restricted Stock Units

Low SignificanceDecember 15, 2025 at 7:02:56 PM EST

SYNOPSYS INC

$SNPS4CIK: 0000883241

Subscribe to track SNPS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Synopsys (SNPS) CRO Awarded Restricted Stock Units

Company: SYNOPSYS INC (SNPS) Form: 4 | Filed: 2025-12-15 Significance: Low

Insider: Ellow Michael Title: Chief Revenue Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 24,286 (Restricted Stock Units) • Price: $0.00 • Value: $0 • Owned After: 24,286 units

Key Insight: This is a routine equity grant as part of executive compensation. The shares represent 0.013% of total outstanding shares, a minimal dilution impact.

Market Context: Such grants are a standard practice for large-cap tech companies like Synopsys to retain and incentivize key executives.

Comprehensive Analysis

SEC Filing Analysis: SYNOPSYS INC (SNPS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Revenue Officer received a routine grant of 24,286 Restricted Stock Units (RSUs) as part of their compensation package.
  • Market Impact: Neutral. This is a non-market transaction and a standard form of executive compensation with minimal immediate market impact.

Company Information

FieldValue
CompanySYNOPSYS INC
Ticker SymbolSNPS
CIK0000883241
IndustrySERVICES-PREPACKAGED SOFTWARE

Insider Information

FieldValue
NameEllow Michael
CIK0001615442
Title/PositionChief Revenue Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-12
Transaction CodeA (Grant)
Security TypeRestricted Stock Units
Shares Involved24,286
Price Per Share$0.00
Total Value$0
Shares Owned After24,286
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted24,286
% of Shares Outstanding0.013%
Post-Transaction Ownership24,286 units (0.013% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Synopsys is a large-cap company with a market capitalization of $72.41 billion. This equity grant is immaterial in value relative to the company's size.
  • Ownership Concentration: This grant establishes the insider's initial reported holdings in this security type, representing a very small fraction (0.013%) of total shares outstanding.
  • Dilution Impact: The issuance of 24,286 shares upon vesting will have a negligible dilutive effect on existing shareholders, increasing the share count by only 0.013%.
  • Transaction Significance: The transaction is classified as low significance because it is a non-cash grant and represents a tiny fraction of the company's shares outstanding and market capitalization.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Equity grants are a standard and expected part of executive compensation plans, particularly in the technology sector. They do not reflect an insider's market sentiment in the same way an open-market purchase or sale does.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open-market transaction and will not directly affect trading volume.
  • Sentiment Indicator: Neutral. The market generally views routine RSU grants as a standard cost of doing business to retain talent.

Additional Context

Transaction Notes

  • Vesting Schedule: According to footnote 2, one-sixth (1/6) of the units will vest on June 15, 2026, followed by five equal semi-annual installments, contingent on the insider's continued service. This long vesting schedule aligns the executive's interests with long-term shareholder value.
Topics:#SECFiling#InsiderTrading#SNPS#Synopsys#Form4#RSU#EquityGrant#ExecutiveComp#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.